BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 11345288)

  • 41. Effects of TNFalpha on the human nasal mucosa in vivo.
    Widegren H; Korsgren M; Andersson M; Greiff L
    Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity.
    Ciprandi G; Pronzato C; Passalacqua G; Ricca V; Grögen J; Mela GS; Varese P; Bertolini C; Bagnasco M; Canonica GW
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1088-96. PubMed ID: 8977510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
    Parameswaran K; Fanat A; O'Byrne PM
    Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
    Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
    Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn).
    Dykewicz MS; Kaiser HB; Nathan RA; Goode-Sellers S; Cook CK; Witham LA; Philpot EE; Rickard K
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):44-8. PubMed ID: 12877448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis.
    Prenner BM; Lanier BQ; Bernstein DI; Shekar T; Teper A
    J Allergy Clin Immunol; 2010 Jun; 125(6):1247-1253.e5. PubMed ID: 20434199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
    Bachert C; El-Akkad T
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
    Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
    Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis.
    Vancheri C; Mastruzzo C; Armato F; Tomaselli V; Magrì S; Pistorio MP; LaMicela M; D'amico L; Crimi N
    J Allergy Clin Immunol; 2001 Nov; 108(5):703-8. PubMed ID: 11692092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
    Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
    Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids.
    Sivam A; Jeswani S; Reder L; Wang J; DeTineo M; Taxy J; Baroody FM; Naclerio RM; Pinto JM
    Am J Rhinol Allergy; 2010; 24(4):286-90. PubMed ID: 20819468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis.
    Boot JD; Chandoesing P; de Kam ML; Mascelli MA; Das AM; Gerth van Wijk R; de Groot H; Verhoosel R; Hiemstra PS; Diamant Z
    J Investig Allergol Clin Immunol; 2008; 18(6):433-42. PubMed ID: 19123434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.